Viewing Study NCT02073227


Ignite Creation Date: 2025-12-25 @ 5:05 AM
Ignite Modification Date: 2026-01-22 @ 12:17 AM
Study NCT ID: NCT02073227
Status: COMPLETED
Last Update Posted: 2014-09-09
First Post: 2014-02-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components
Sponsor: Janssen Research & Development, LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-02
Start Date Type: None
Primary Completion Date: 2014-06
Primary Completion Date Type: ACTUAL
Completion Date: 2014-06
Completion Date Type: ACTUAL
First Submit Date: 2014-02-25
First Submit QC Date: None
Study First Post Date: 2014-02-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-09-08
Last Update Post Date: 2014-09-09
Last Update Post Date Type: ESTIMATED